AI Science Tracker

PepMLM designs experimentally binding target-conditioned peptide ligands, including peptides used for targeted protein degradation

Cornell University; and collaborating institutions · 13 Aug 2025 · biology

Discovery

PepMLM designs experimentally binding target-conditioned peptide ligands, including peptides used for targeted protein degradation

PepMLM fine-tunes ESM-2 using masked-language modeling conditioned on a target protein sequence to generate de novo linear peptide binders without structural input. In the reported experiments, selected peptides showed sequence-specific binding to targets including NCAM1 and AMHR2; incorporation into ubiquitin-based antibody constructs enabled targeted degradation of disease-relevant proteins, including Huntington’s disease drivers and viral phosphoproteins.

Technology: PepMLM, ESM-2 fine-tuned with target-sequence-conditioned masked language modeling

Family ESM / ESMFold: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: In the reported experiments, selected peptides showed sequence-specific binding to targets including NCAM1 and AMHR2; incorporation into ubiquitin-based antibody constructs enabled targeted degradation of disease-relevant proteins, including Huntington’s disease drivers and viral phosphoproteins.
  • Still unknown: The reported evidence is preclinical binding/degradation assays, not therapeutic efficacy, pharmacokinetics or safety. The article notes that experimental optimization/stabilization of its selected peptides was not performed and further validation is needed for viral-target applications. Primary publisher full text/abstract checked; no independent replication assessed.
  • AI role: Given a target protein sequence, PepMLM generates candidate linear binder peptide sequences by reconstructing masked peptide regions. The authors tested selected designs in binding and degradation assays and reported target-specific activity in the stated systems.

Evidence sources: https://www.nature.com/articles/s41587-025-02761-2

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 103 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.